The Journal of Community and Supportive OncologyApprovals and presentations flag notable advances in the hem-onc spaceMarch 23, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology TimesEMA recommends safety measures for idelalisibMarch 22, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaFollicular Lymphoma
Hematology TimesDrug may best BSC in some high-risk MDS patientsMarch 18, 2016AnemiaLeukemia, Myelodysplasia, TransplantationMyelodysplastic Syndrome
Hematology TimesInhibitor exhibits activity against resistant AMLMarch 18, 2016Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesFinancial burdens reduce QOL for cancer survivorsMarch 17, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Hematology NewsRPS15 mutations prevalent in aggressive chronic lymphocytic leukemiaMarch 16, 2016CLLLeukemia, Myelodysplasia, Transplantation
Hematology TimesStarting all CML patients on imatinib could cut costs, team saysMarch 16, 2016Leukemia, Myelodysplasia, TransplantationCML
Hematology NewsIdelalisib use halted in six combo therapy trials, FDA announcesMarch 15, 2016Indolent LymphomaCLLLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology TimesProtein plays key role in B-ALL subtypeMarch 15, 2016Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesIdelalisib trials stopped due to AEsMarch 15, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesAEs prompt EMA review of idelalisibMarch 13, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaFollicular Lymphoma
Hematology TimesClass of drugs could treat B-cell malignanciesMarch 12, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple Myeloma
Hematology NewsGuidelines on asparaginase hypersensitivity and silent inactivation in ALLMarch 11, 2016ALLLeukemia, Myelodysplasia, Transplantation
Hematology TimesAllele associated with poor outcome in CLLMarch 11, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesStudy elucidates MYC’s role in T-ALLMarch 11, 2016Leukemia, Myelodysplasia, TransplantationALL
